Clinical trial
Concomitant and Sequential Radiohormonotherapy in Adjuvant Breast Cancer
NCT00208273 · Institut du Cancer de Montpellier - Val d'Aurelle, Other · Completed
Key facts
| NCT number | NCT00208273 |
|---|---|
| Title | Concomitant and Sequential Radiohormonotherapy in Adjuvant Breast Cancer |
| Official title | A Phase II Randomized Study to Compare Skin Late Toxicities of Concomitant Letrozole-Radiotherapy and Radiotherapy Followed by Letrozole as Adjuvant Therapy for Postmenopausal Women With Receptor (ER and/or PgR) Positive Tumors |
| Lead sponsor | Institut du Cancer de Montpellier - Val d'Aurelle, Other |
| Collaborators | Novartis Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | Letrozole - Concomitant, Letrozole - Sequential |
| Enrollment | 150 |
| Start date | Jan 1, 2005 |
| Primary completion | Jan 1, 2007 |
| Completion | Feb 1, 2007 |
| First posted | Sep 21, 2005 |
| Last update posted | Jun 2, 2021 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: